Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

01 juil. 2025 07h15 HE | Source: Bio Usawa Inc

Bio Usawa Biotechnology and Bioeq AG Partner to Create Widespread Access to Vision-Saving Medicine Across Sub-Saharan Africa

Bio Usawa Biotechnology Ltd. and Bioeq AG today announced a partnership to bring a life-changing biosimilar of ranibizumab to Sub-Saharan Africa.
22 mai 2025 10h15 HE | Source: Bio Usawa Inc

Bio Usawa and Pacific Environmental Technologies Announce Landmark Partnership to Develop and Deploy Modular cGMP Biomanufacturing Units for Africa

Bio Usawa announced an agreement with Pacific Environmental Technologies to design, build, and deploy state-of-the-art, modular biomanufacturing units.
26 févr. 2025 07h15 HE | Source: Bio Usawa Inc

Bio Usawa Appoints Dr. Patrick Lukulay as Chief Operating Officer

Bio Usawa, a pioneering biotechnology company dedicated to developing affordable monoclonal antibodies in Africa, appointed Dr. Patrick Lukulay as COO.
17 déc. 2024 10h15 HE | Source: Bio Usawa Inc

Bio Usawa Names Former Ghana Food and Drug Authority Director Eric Karikari-Boateng as Head of Global Regulatory Strategy

Bio Usawa, Inc., a company committed to delivering affordable biotherapies in Africa, named Eric Karikari-Boateng its Head of Global Regulatory Strategy
21 nov. 2024 12h46 HE | Source: Bio Usawa Inc

Bio Usawa and Rwandan Government Sign a Memorandum of Understanding to Manufacture Affordable Biologics in Africa

Bio Usawa and the Rwanda Development Board have partnered to establish Rwanda’s first manufacturing plant for affordable treatments for serious eye disease